IGF1R and breast carcinoma: However, IRS-2 is recruited to and activated by additional surface receptors, including integrins, growth hormone receptor and cytokine receptors, suggesting that membrane IRS-2 staining in breast cancer could represent activity of IGF-1R-dependent and -independent pathways [12,93].